| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,920 |
4,922 |
$277K |
| 99493 |
|
663 |
613 |
$53K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,985 |
1,576 |
$48K |
| 99349 |
|
890 |
637 |
$32K |
| 99215 |
Prolong outpt/office vis |
512 |
445 |
$32K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
184 |
166 |
$12K |
| 99492 |
|
126 |
125 |
$11K |
| 99443 |
|
152 |
129 |
$6K |
| 99408 |
|
413 |
364 |
$4K |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
100 |
88 |
$3K |
| 95923 |
|
50 |
41 |
$3K |
| 87631 |
|
65 |
41 |
$3K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
65 |
61 |
$3K |
| 99442 |
|
63 |
54 |
$2K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
59 |
31 |
$1K |
| 99344 |
|
26 |
26 |
$1K |
| 95921 |
|
50 |
41 |
$1K |
| 94060 |
|
61 |
50 |
$1K |
| 99000 |
|
118 |
112 |
$986.89 |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
23 |
12 |
$975.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
42 |
29 |
$965.31 |
| 99491 |
Ccm add 20min |
175 |
166 |
$815.01 |
| 92100 |
|
30 |
25 |
$721.99 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
65 |
41 |
$721.21 |
| 87481 |
|
42 |
31 |
$707.52 |
| 87500 |
|
42 |
31 |
$560.12 |
| 87653 |
|
42 |
31 |
$560.12 |
| 87641 |
|
42 |
31 |
$560.12 |
| 93000 |
|
59 |
53 |
$513.31 |
| 99497 |
|
399 |
345 |
$403.34 |
| 99490 |
Ccm add 20min |
400 |
386 |
$369.57 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
23 |
12 |
$325.00 |
| 99441 |
|
13 |
12 |
$298.19 |
| 99437 |
|
162 |
154 |
$242.40 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
65 |
52 |
$196.03 |
| 99487 |
Ccm add 20min |
284 |
261 |
$190.98 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
19 |
12 |
$164.11 |
| 99439 |
|
292 |
291 |
$157.52 |
| 82947 |
|
68 |
53 |
$141.66 |
| 93040 |
|
32 |
30 |
$124.88 |
| 81002 |
|
48 |
44 |
$90.32 |
| 99001 |
|
31 |
29 |
$59.40 |
| 3044F |
|
595 |
462 |
$40.00 |
| 93923 |
|
52 |
42 |
$33.60 |
| 3074F |
|
1,303 |
962 |
$25.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
67 |
52 |
$4.59 |
| 94761 |
|
89 |
50 |
$2.94 |
| 87640 |
|
42 |
31 |
$0.00 |
| 99489 |
Ccm add 20min |
213 |
200 |
$0.00 |
| 1170F |
|
352 |
299 |
$0.00 |
| 96127 |
|
490 |
415 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
263 |
238 |
$0.00 |
| 1126F |
|
116 |
101 |
$0.00 |
| 3008F |
|
278 |
252 |
$0.00 |
| 1125F |
|
205 |
178 |
$0.00 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
58 |
47 |
$0.00 |
| 1101F |
|
170 |
149 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
15 |
13 |
$0.00 |
| 1111F |
|
51 |
43 |
$0.00 |
| 1220F |
|
112 |
106 |
$0.00 |
| 92548 |
|
49 |
40 |
$0.00 |
| G0136 |
Administration of a standardized, evidence-based assessment of physical activity and nutrition, 5-15 minutes, not more often than every 6 months |
33 |
32 |
$0.00 |
| G0022 |
Community health integration services, each additional 30 minutes per calendar month (list separately in addition to g0019) |
57 |
56 |
$0.00 |
| G9664 |
Patients who are currently statin therapy users or received an order (prescription) for statin therapy |
17 |
15 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
16 |
14 |
$0.00 |
| 99401 |
|
801 |
673 |
$0.00 |
| 0521F |
|
384 |
332 |
$0.00 |
| 1159F |
|
4,828 |
2,929 |
$0.00 |
| 4274F |
|
159 |
145 |
$0.00 |
| 3078F |
|
1,296 |
958 |
$0.00 |
| 1160F |
|
4,797 |
2,919 |
$0.00 |
| 1090F |
|
129 |
110 |
$0.00 |
| 3288F |
|
274 |
241 |
$0.00 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
21 |
18 |
$0.00 |
| 4040F |
|
135 |
121 |
$0.00 |
| 96160 |
|
54 |
48 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
17 |
15 |
$0.00 |
| G0019 |
Community health integration services performed by certified or trained auxiliary personnel, including a community health worker, under the direction of a physician or other practitioner; 60 minutes per calendar month, in the following activities to address social determinants of health (sdoh) need(s) that are significantly limiting the ability to diagnose or treat problem(s) addressed in an initiating visit: person-centered assessment, performed to better understand the individualized context of the intersection between the sdoh need(s) and the problem(s) addressed in the initiating visit. ++ conducting a person-centered assessment to understand patient's life story, strengths, needs, goals, preferences and desired outcomes, including understanding cultural and linguistic factors and including unmet sdoh needs (that are not separately billed). ++ facilitating patient-driven goal-setting and establishing an action plan. ++ providing tailored support to the patient as needed to accomplish the practitioner's treatment plan. practitioner, home-, and community-based care coordination. ++ coordinating receipt of needed services from healthcare practitioners, providers, and facilities; and from home- and community-based service providers, social service providers, and caregiver (if applicable). ++ communication with practitioners, home- and community-based service providers, hospitals, and skilled nursing facilities (or other health care facilities) regarding the patient's psychosocial strengths and needs, functional deficits, goals, preferences, and desired outcomes, including cultural and linguistic factors. ++ coordination of care transitions between and among health care practitioners and settings, including transitions involving referral to other clinicians; follow-up after an emergency department visit; or follow-up after discharges from hospitals, skilled nursing facilities or other health care facilities. ++ facilitating access to community-based social services (e.g., housing, utilities, transportation, food assistance) to address the sdoh need(s). health education- helping the patient contextualize health education provided by the patient's treatment team with the patient's individual needs, goals, and preferences, in the context of the sdoh need(s), and educating the patient on how to best participate in medical decision-making. building patient self-advocacy skills, so that the patient can interact with members of the health care team and related community-based services addressing the sdoh need(s), in ways that are more likely to promote personalized and effective diagnosis or treatment. health care access / health system navigation. ++ helping the patient access healthcare, including identifying appropriate practitioners or providers for clinical care and helping secure appointments with them. facilitating behavioral change as necessary for meeting diagnosis and treatment goals, including promoting patient motivation to participate in care and reach person-centered diagnosis or treatment goals. facilitating and providing social and emotional support to help the patient cope with the problem(s) addressed in the initiating visit, the sdoh need(s), and adjust daily routines to better meet diagnosis and treatment goals. leveraging lived experience when applicable to provide support, mentorship, or inspiration to meet treatment goals |
68 |
67 |
$0.00 |
| 99072 |
|
15 |
15 |
$0.00 |
| 1100F |
|
17 |
16 |
$0.00 |